Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Citius Pharmaceuticals (CTXR) stocks in Canada
Learn how to easily invest in Citius Pharmaceuticals stocks.
Citius Pharmaceuticals is a biotechnology business based in the US. Citius Pharmaceuticals stocks (CTXR.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.16 – an increase of 0.4% over the previous week. Citius Pharmaceuticals employs 15 staff and has a market cap (total outstanding stock value) of $128.9 million.
How to buy stocks in Citius Pharmaceuticals
- Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CTXR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Citius Pharmaceuticals?
- Has coronavirus impacted Citius Pharmaceuticals shares?
- Citius Pharmaceuticals shares summary
- Compare share dealing platforms
- Is Citius Pharmaceuticals stock a buy or sell?
- Citius Pharmaceuticals performance over time
- Citius Pharmaceuticals's financials
- How volatile are Citius Pharmaceuticals shares?
- Does Citius Pharmaceuticals pay a dividend?
- Have Citius Pharmaceuticals shares ever split?
- Other common questions
Citius Pharmaceuticals stock price (NASDAQ:CTXR)Use our graph to track the performance of CTXR stocks over time.
Citius Pharmaceuticals shares at a glance
|Latest market close||$0.90|
|52-week range||$0.88 - $4.56|
|50-day moving average||$1.46|
|200-day moving average||$1.71|
|Wall St. target price||$6.67|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.20|
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Citius Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Citius Pharmaceuticals price performance over time
|1 week (2022-05-09)||-4.26%|
|1 month (2022-04-19)||-30.91%|
|3 months (2022-02-17)||-49.63%|
|6 months (2021-11-15)||N/A|
|1 year (2021-05-19)||-58.83%|
|2 years (2020-05-19)||12.70%|
|3 years (2019-05-17)||1.38|
|5 years (2017-05-19)||124.28%|
Citius Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||-17.82%|
|Return on equity TTM||-32.1%|
|Market capitalisation||$128.9 million|
TTM: trailing 12 months
Citius Pharmaceuticals share dividends
We're not expecting Citius Pharmaceuticals to pay a dividend over the next 12 months.
Have Citius Pharmaceuticals's shares ever split?
Citius Pharmaceuticals's shares were split on a 1:15 basis on 8 June 2017. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Citius Pharmaceuticals shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Citius Pharmaceuticals shares which in turn could have impacted Citius Pharmaceuticals's share price.
Citius Pharmaceuticals share price volatility
Over the last 12 months, Citius Pharmaceuticals's shares have ranged in value from as little as $0.88 up to $4.56. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Citius Pharmaceuticals's is 1.4113. This would suggest that Citius Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Citius Pharmaceuticals overview
Citius Pharmaceuticals, Inc. , a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome; and I/ONTAK, an engineered IL-2 diphtheria toxin fusion protein for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. .
Stocks similar to Citius Pharmaceuticals
Citius Pharmaceuticals in the news
Citius Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference on May 24, 2022
SEC filings reveal massive selling in media names, including Disney and Comcast
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2022 Financial Results and Provides Business Update
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of online gaming stocks.Read more…
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.Read more…
Here’s what you need to know about investing in the propane industry, including 3 popular propane stocks to watch.Read more…
More guides on Finder
How to buy Hanover Bancorp, Inc. (HNVR) stock in Canada when it goes public
Everything we know about the Hanover Bancorp, Inc. IPO, plus information on how to buy in.
How to buy PrimeBlock stock in Canada when it goes public
Everything we know about the PrimeBlock IPO, plus information on how to buy in.
How to buy Actelis Networks (ASNS) stock in Canada when it goes public
Everything we know about the Actelis Networks IPO, plus information on how to buy in.
How to buy ProFrac Holding Corp (PFHC) stock in Canada when it goes public
Everything we know about the ProFrac Holding Corp IPO, plus information on how to buy in.
How to buy Wytec International (WYTC) stock in Canada when it goes public
Everything we know about the Wytec International IPO, plus information on how to buy in.
Here are some of the best stocks for inflation periods to reduce the negative impacts of inflation on your portfolio.
HSBC InvestDirect Review
Choose from many account and investment types to invest in global markets, but expect to pay high commissions with HSBC InvestDirect, which doesn’t have an app.
Our Flahmingo review tells you how to buy fractional shares of some of your favourite US companies with as little as $1.
How to buy Expeditors International of Washington stock in Canada
Steps to owning and managing EXPD stock, with 24-hour and historical pricing before you buy.
How to buy Perseus Mining stock in Canada
Steps to owning and managing PRU stock, with 24-hour and historical pricing before you buy.